Holcim Group Services Ltd
Holcim Group Services Ltd
- ISIN: CH0012214059
- Land: Schweiz
Nachricht vom 10.09.2021 | 06:30
Holcim divests business in Brazil
Holcim Group Services Ltd / Key word(s): Miscellaneous
Holcim has signed an agreement with CSN (Companhia Siderúrgica Nacional) for the divestment of its business in Brazil for an enterprise value of USD 1.025 billion. This divestment includes Holcim's five integrated cement plants, four grinding stations, six aggregates sites and 19 ready-mix concrete facilities.
This divestment strengthens the company's balance sheet, significantly reducing its debt ratio. Advancing its portfolio optimization, Holcim will use the proceeds to invest in its Solutions & Products business, building on the Firestone acquisition.
Jan Jenisch, CEO: 'This divestment is another step in our transformation to become the global leader in innovative and sustainable building solutions giving us the flexibility to continue investing in attractive growth opportunities. We are pleased to have found a responsible buyer with CSN that will develop the Brazilian business over the long term.'
While Holcim divests its activities in Brazil, Latin America is a core strategic growth region for the company. Building on strong positions in all its markets, Holcim recently invested in an additional clinker line in Malagueno, Argentina, a new grinding station in Yucatan, Mexico, and in the continuous growth of its Disensa retail network. Holcim also introduced its Firestone GacoFlex line in Mexico as the first step in developing its roofing systems business across Latin America.
More information is available on www.holcim.com
Important disclaimer - forward-looking statements:
This document contains inside information within the meaning of the Market Abuse Regulation (EU) (No 596/2014).
End of ad hoc announcement
GBC im Fokus
IGEA Pharma N.V. Realignment to CBD extraction
The goal is to become the quality and cost leader in the field of CBD in Europe. To this end, a GMP pharma compliant plant is being built in Switzerland. The supercritical CO2 extraction process is to be used to achieve the highest standard of quality. The CBD market is growing strongly and with the focus on quality leadership and pure extraction, IGEA Pharma's new business model should be able to occupy an attractive niche market. With the proprietary supercritical CO2-extraction technology, other markets such as vanilla, rose or rosemary can be developed in the medium term. Based on our DCF model, we have determined a fair value of € 1.05 (CHF 1.13) per share and assign a BUY rating.
Der AKTIONÄR News
06. Dezember 13:15 Bitcoin: "High-Risk" und "Chance auf 100.000 Dollar"
06. Dezember 13:45 Munich Re: Das schaut viel besser aus
06. Dezember 14:15 Allianz dealt mit BASF – Aktie hat Rückenwind
06. Dezember 14:15 Deutsche Nebenwerte: Starke Aussichten
06. Dezember 14:18 Thyssenkrupp auf Talfahrt - das macht Hoffnung auf die Trendwende
FY 2020/2021 Financial Results
16. Dezember 2021
Original-Research: PSI AG (von First Berlin Equity Research GmbH): Hinzufügen
06. Dezember 2021